Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · April 16, 2014

Management of Major Bleeding in Atrial Fibrillation With Rivaroxaban vs Warfarin

European Heart Journal

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Heart Journal
Management of Major Bleeding Events in Patients Treated With Rivaroxaban vs, Warfarin: Results From the ROCKET AF Trial
Eur Heart J 2014 Apr 03;[EPub Ahead of Print], JP Piccini, J Garg, MR Patel, Y Lokhnygina, SG Goodman, RC Becker, SD Berkowitz, G Breithardt, W Hacke, JL Halperin, GJ Hankey, CC Nessel, KW Mahaffey, DE Singer, RM Califf, KA Fox

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading